We confirmed the signatures we found in the FA SCC clinical data in our cell lines by measuring mRNA expression of TFEB and MCOLN1 in multiple in vitro FA-mutant and WT cell models. This evidence concerns the gene MCOLN1 and Friedreich ataxia.